Skip to content Skip to footer

International Cannabis Weekly: 256

July 15, 2022

Highlights

Share this story

HAVING A FAIR RELATIONSHIP WITH PATIENTS ‘ISN’T JUST THE RIGHT THING TO DO, IT SIMPLY MAKES BUSINESS SENSE’

Mary Biles, author of The CBD Book and host of the podcast ‘Cannabis Voices’, asks whether for all the rhetoric around patient engagement across the cannabis industry, the message has really sunk in.

“As the dust settles after Cannabis Europa 2022 and industry movers and shakers have returned home, wallets stuffed with business cards and follow-up calls to make, I can’t help but feel that one message which was hammered home throughout the two-day proceedings has failed to make an impact: the call to create a patient-centred cannabis industry.”

READ MORE »

THE ALBANIAN GOVERNMENT SET OUT PLANS TO LEGALISE MEDICAL CANNABIS

READ MORE »

THE GERMAN FEDERAL DRUG COMMISSIONER IS DEMANDING A DEBATE ON THE THC CAP

READ MORE »

Highlights

Share this story
Europe
  • France re-enters the cannabis industry after more than a fifty year hiatus with a 2-year pilot programme.
  • The Bosnian government’s set to legalise medical cannabis after a proposal was sent to the Council of Ministers.
  • Seven companies dedicated to cultivating cannabis have formed the Medicinal Cannabis Business Association of Spain.
  • Akanda Corp. has announced it will supply Tetra with pharmaceutical grade cannabis flower in a microdose cap form.
  • MGC Pharmaceuticals had its best week on the stock market since August 2021, seeing its stock jump by over 50%.
  • WMG Pharma expands its offering by supporting companies with the development of new cannabis products.
  • CBD, in combination with clobazam, has benefited the treatment of children with rare forms of very severe epilepsy.
  • Little Green Pharma signs a medical cannabis supply agreement with German pharmaceutical wholesaler Sante GmbH.

Highlights

Share this story
United States
  • NYPD has reversed the decision on testing officers for cannabis, after initially stating they would cease testing.
  • A group of financial institutions have formally asked US lawmakers to pass a banking amendment in the defence bill.
  • North Dakota residents have collected enough signatures to put cannabis legalisation on the November ballot.
  • Last Prisoner Project says Brittney Griner’s trial in Russia should nudge US lawmakers to update cannabis laws.
  • A Pennsylvanian governor has signed a bill that protects banks from working with legal cannabis businesses.
  • Vermont is giving up on its hemp programme less than a year after a state plan for the sector was approved.
  • Evergreen Herbal and Two Heads Co. have announced that they have entered into an exclusive distribution agreement.
  • A number of Democrat senators have called for Biden to issue pardons for all non-violent cannabis offences.

Highlights

Share this story
Sponsorship

Prohibition Partners’ next report, The North American Report: Third Edition, will explore the continent’s challenges, opportunities, current consumer behaviours and anticipated legislation on both the adult-use and medical sides, as well as sales projections from 2022 to 2026. Sponsorship applications for the report are closing soon.

Get in touch for unique opportunities to promote your business and brand to the most influential figures in the global cannabis industry: from politics to pharma, and cannabis to consumer-packaged goods. As companies and investors scramble to get a foothold in the market, sponsorship is an invaluable opportunity to put your brand front and centre in one of the industry’s most influential reports.

BECOME A SPONSOR »

Highlights

Share this story
Canada
  • Tilray Brands Inc. has confirmed that it has closed its C$155 million investment in HEXO Corp.
  • British Columbian residents can now get recreational cannabis delivered to their homes through Canada Post.
  • Fire & Flower and Pineapple Express launch a same-day recreational cannabis delivery service in British Columbia.
  • Nextleaf Solutions has announced the launch of its new CBD vape under its brand Glacial Gold.
  • Organigram announces that its Q3 revenue has increased by 20% sequentially to C$38.1 million.
  • High Tide has announced that its Canna Cabana retail cannabis store has officially opened in British Columbia.

Highlights

Share this story
LATAM & The Caribbean
  • Ceub students in Brazil have carried out a study that proves the benefits of CBD against childhood epilepsy.
  • A draft law is under review in Peru’s parliament that would exempt hemp from the country’s drug laws.
  • Between Blueberries Medical Corp. and Lab Victoria, the supply of cosmetics with CBD continues to grow in Argentina.
  • The Santiago Court of Appeals in Chile has authorised a project to cultivate dried industrial hemp flowers.
  • Anvisa authorises the manufacture of Cannabis Active Pharmaceutical Ingredient (API) in Brazil.
  • The case for medical cannabis use for pets grows in Brazil, where it is thought that 500,000 animals could benefit.
  • Senator Bolivar confirms that the legalisation of cannabis for adult-use will be discussed in the Colombian congress.

Highlights

Share this story
Upcoming Event

 

Off the back of an exclusive reveal at Cannabis Europa last month, Atalis – the intelligent cannabis marketplace, powered by Prohibition Partners – will be exhibiting at ICBC in Berlin on 19-20 July. If you’re in Berlin next week, you can visit the Atalis team at booths 271/272 to find out more about the marketplace, or to have a live product demonstration.

To book your demonstration in advance, simply click the button below and select a day and time that best suits you.

PRE-BOOK A LIVE DEMO »

Highlights

Share this story
APAC
  • Bespoke Life Science has launched Thailand’s first cannabis dispensary for educational and medicinal purposes.
  • Over 120,000 people have registered to cultivate cannabis after new legislation came into effect in Thailand in June.
  • Hygrovest continues to diversify its investment portfolio within the cannabis sector for the prospect of higher growth.
  • Neurotech International announces that its medical cannabis formulation has a positive impact on children with autism.
  • Cannatrek will accelerate the construction of its medical cannabis facility in Victoria after securing debt funding.
  • MediPharm has agreed a deal to sell its Australian subsidiary to OneLife Botanicals for A$6.9 million.

Highlights

Share this story
Africa & The Middle East
  • A recent ruling in Israel requires Direct Insurance Company to refund a patient for the purchase of medical cannabis.
  • Soweto in South Africa holds its first cannabis festival to remove stigma and provide education about the plant.
  • South Africa’s policy head for cannabis says a commercialised cannabis sector could have significant benefits.
Latest Issues

259

258

257

256

255

254

Insights

On the global cannabis industry

International Cannabis Weekly newsletter brings you the most important developments, news and informed commentary on the global cannabis industry. Join our community of 70,000+ subscribers.